Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Masuyama

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
American Heart Journal|December 1, 1989
Left ventricular diastolic filling in coronary artery diseaseT Masuyama
Brain Research|June 13, 1997
Antinociceptive involvement of substance P in the spinal cord of mice: dose effects of substance P on the behavior elicited by intrathecally administered NMDAT Masuyama, T Shimizu
European Heart Journal|November 5, 1997
Doppler evaluation of left ventricular filling in congestive heart failureT Masuyama, R L Popp
Journal of Cardiology|December 13, 1997
[Cardiovascular imaging in-a-month. A 60-year-old woman with systolic murmur after repeat mitral valve replacement]R Doi, T Masuyama, S Beppu
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 2011
Chronic toxicity and carcinogenicity of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the ratA Otabe, T Fujieda, T Masuyama
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 2011
Evaluation of the teratogenic potential of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat and rabbitA Otabe, T Fujieda, T Masuyama
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 2011
In vitro and in vivo assessment of the mutagenic activity of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame)A Otabe, T Fujieda, T Masuyama
Naika. Internal Medicine|February 1, 1970
[14 cases of chronic thyroiditis, thyroid adenoma and thyroid cancer with signs of acute inflammatory changes similar to subacute thyroiditis]T Tachibana, T Masuyama, T Kita
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|May 4, 2000
[Clinical implications of ultrasonic tissue characterization for atherosclerotic carotid intima-media]S Takiuchi, H Rakugi, T Masuyama, et al.
Journal of Cardiology|September 29, 1999
[A 49-year-old man with general fatigue and an increase in cardiothoracic ratio]K Yamamoto, T Masuyama, M Hori
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
American Heart Journal|December 1, 1989
Left ventricular diastolic filling in coronary artery diseaseT Masuyama
Brain Research|June 13, 1997
Antinociceptive involvement of substance P in the spinal cord of mice: dose effects of substance P on the behavior elicited by intrathecally administered NMDAT Masuyama, T Shimizu
European Heart Journal|November 5, 1997
Doppler evaluation of left ventricular filling in congestive heart failureT Masuyama, R L Popp
Journal of Cardiology|December 13, 1997
[Cardiovascular imaging in-a-month. A 60-year-old woman with systolic murmur after repeat mitral valve replacement]R Doi, T Masuyama, S Beppu
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 2011
Chronic toxicity and carcinogenicity of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the ratA Otabe, T Fujieda, T Masuyama
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 2011
Evaluation of the teratogenic potential of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat and rabbitA Otabe, T Fujieda, T Masuyama
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 2011
In vitro and in vivo assessment of the mutagenic activity of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame)A Otabe, T Fujieda, T Masuyama
Naika. Internal Medicine|February 1, 1970
[14 cases of chronic thyroiditis, thyroid adenoma and thyroid cancer with signs of acute inflammatory changes similar to subacute thyroiditis]T Tachibana, T Masuyama, T Kita
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|May 4, 2000
[Clinical implications of ultrasonic tissue characterization for atherosclerotic carotid intima-media]S Takiuchi, H Rakugi, T Masuyama, et al.
Journal of Cardiology|September 29, 1999
[A 49-year-old man with general fatigue and an increase in cardiothoracic ratio]K Yamamoto, T Masuyama, M Hori
Pageof 17